Table 1.
Biomarkers for MetS before/during/after intervention
| Results | Pre-intervention | Mid-intervention | Post-intervention | Percent change |
|---|---|---|---|---|
| HOMA-IR (<1.0) | 31.0 | 6.3 | 3.5 | −88.8% |
| Tri/HDL ratio (<2.0) | 4.9 | 3.3 | 2.2 | −55.5% |
| WHtR (<0.5) | 0.62 | 0.61 | .58 | −6.45% |
| Fasting insulin mU/L (3-5) | 97.2 | 21.3 | 14.3 | −85.3% |
| Fasting glucose mg/dL (70-90) | 129 | 119 | 98 | −24.0% |
| HgA1c (%) | 7.8% (diabetic) | 5.6% | 5.5% (normal) | −29.5% |
| Triglycerides mg/dL (<150) | 137 | 96 | 83 | −39.4% |
| HDL mg/dL (>50) | 28 | 29 | 38 | +35.7% |
| LDL mg/dL (<100) | 74 | 65 | 61 | −17.6% |
| VLDL mg/dL (9-13) | 27.4 | 19.2 | 16.6 | −39.4% |
| Weight | 257.2 | 250.4 | 243.0 | −5.5% |
| Body fat % (<30%) | 39.8% | 37.4% | 36.8% | −3% |